Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Thalassemia gene detection method based on fluorescence labeling quantitation PCR (Polymerase Chain Reaction) technology

A fluorescent labeling quantitative, thalassemia technology, applied in the field of medical detection

Inactive Publication Date: 2013-08-21
钦州市妇幼保健院
View PDF2 Cites 28 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no combination of AS-PCR method and Gap-PCR method with fluorescence-labeled quantitative PCR technology to realize the effect of single-tube multiplex PCR technology on α-thalassemia-- SEA type (Southeast Asian type), -α 3.7 ,-α 4.2 ,-- THAI (Thai type), α CS alpha, alpha QS α and α WS α, and β thalassemia HPFH-SEA (abnormal hemoglobin combined with hereditary persistent fetal hemoglobin), Southeast Asian deletion type (HPFH-SEA) and DBT (Chinese type) thalassemia genotype detection reports

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Thalassemia gene detection method based on fluorescence labeling quantitation PCR (Polymerase Chain Reaction) technology
  • Thalassemia gene detection method based on fluorescence labeling quantitation PCR (Polymerase Chain Reaction) technology
  • Thalassemia gene detection method based on fluorescence labeling quantitation PCR (Polymerase Chain Reaction) technology

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0083] Embodiment 1: detection method of the present invention

[0084] (1) Primer design

[0085] (1) Through the Blast function of NCBI, design a DNA fragment with a length of 20 bp and less homology with human DNA sequences as a universal primer. The sequence of the universal primer is: 5'-CTCGACACGCATCTGCTCAG-3' (SEQ ID NO: 1) , using 6-FAM fluorescent labeling at the 5' end to obtain universal fluorescent labeling primers;

[0086] In addition, 5'-CTCGACACGCATCTGACGTT-3' (SEQ ID NO: 2) labeled with VIC, 5'-CTCGACACGCATCTGGCGAA-3' (SEQ ID NO: 3) labeled with NED, and 5'- CTCGACACGCATCTGCTACC-3' (SEQ ID NO: 4) has also been designed and can be used in subsequent multicolor fluorescent labeling systems;

[0087] (2) For α-thalassemia -- SEA Type, -α 3.7 ,-α 4.2 ,-- THAI , α CS alpha, alpha QS α and α WS α, and β thalassemia HPFH-SEA and DBT thalassemia genotype sequences, design amplification primer pairs, primer sequences and pairings are as follows:

[0088] 2.1)...

Embodiment 2

[0189] Repeat the method of embodiment 1, difference is, replace sample 1 with sample 2, the result is as follows Figure 6 shown.

[0190] Figure 6 Among them, 2Y1=Y2, CSM, QSN, WSN have peaks, HPFH-W has peaks, and the rest have no peaks.

[0191] Combining with existing test results Figure 1~4 , it can be independently judged that the genotype of sample 2 is -α 3.7 / α CS α genotype thalassemia; and the result graph independently made by the system of the present invention can also directly determine that the genotype of sample 2 is -α 3.7 / α CS Alpha genotype thalassemia. The two are mutually verified, which proves the simplicity of the present invention and the consistency of the results.

Embodiment 3

[0193] Repeat the method of embodiment 1, difference is, replace sample 1 with sample 3, the result is as follows Figure 7 shown.

[0194] Figure 7 Among them, Y1=2Y2, CSN, QSN, and WSW have peaks, HPFH-W has peaks, and the rest have no peaks.

[0195] Combining with existing test results Figure 1~4 , it can be independently judged that the genotype of sample 3 is -α 4.2 / α WS α genotype thalassemia; and the result graph independently made by the system of the present invention can also directly determine that the genotype of sample 3 is -α 4.2 / α WS Alpha genotype thalassemia. The two are mutually verified, which proves the simplicity of the present invention and the consistency of the results.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a thalassemia gene detection method based on a fluorescence labeling quantitation PCR (Polymerase Chain Reaction) technology, and the detection method mainly comprises the following steps of: firstly designing a general fluorescence labeling primer; then designing an amplification primer aiming at a detection site; when the amplification primer is designed, tailing one primer of an amplification primer pair, wherein the tailing sequence is consistent to the sequence of the general fluorescence labeling primer; when PCR reaction is carried out, mixing a tailed primer group and the general fluorescence labeling primer to realize the fluorescence labeling of an amplification product; and after the PCR reaction is finished, placing PCR products into a sequencer, and confirming the lengths of different PCR products through a series of internal references of known molecular weight of a result by utilizing the Genemapper function of the sequencer to judge the genetype of a detected sample. The detection method disclosed by the invention can realize the detection of different genotypes of alpha thalassemia through a single tube.

Description

technical field [0001] The invention relates to the technical field of medical detection, in particular to a thalassemia gene detection method based on fluorescent marker quantitative PCR technology. Background technique [0002] Thalassemia (Mediterranean Anemia), also known as Thalassemia (Thalassemia), Cooley (Cooley) anemia, globin synthesis disorder anemia, referred to as thalassemia. Thalassemia is one of the most common monogenic genetic diseases. Common types of thalassemia include α-thalassemia and β-thalassemia, which are caused by abnormal expression of α-protein gene cluster and β-globin gene cluster, respectively. The disease occurs frequently in the Mediterranean coast, Africa, Latin America, Southeast Asia, East Asia, South Asia, and other tropical and subtropical regions. In my country, Guangxi, Guangdong and Hainan are provinces with high incidence of thalassemia, among which the incidence of α-thalassemia in Guangxi is 15.5%, and the prevalence of α-thalas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/68
Inventor 龙驹叶学和翁勋锦庞婉容
Owner 钦州市妇幼保健院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com